Aapro, M S <br/><br/>
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  May 2003 
 - 1141-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/s0959-8049(03)00198-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Female<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Infusions, Intravenous<br/>Middle Aged<br/>Nausea--chemically induced<br/>Nitrosourea Compounds--administration & dosage<br/>Organophosphorus Compounds--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Vomiting--chemically induced